Literature DB >> 21418714

Clustered lot quality assurance sampling: a tool to monitor immunization coverage rapidly during a national yellow fever and polio vaccination campaign in Cameroon, May 2009.

L Pezzoli1, R Tchio, A D Dzossa, S Ndjomo, A Takeu, B Anya, J Ticha, O Ronveaux, R F Lewis.   

Abstract

We used the clustered lot quality assurance sampling (clustered-LQAS) technique to identify districts with low immunization coverage and guide mop-up actions during the last 4 days of a combined oral polio vaccine (OPV) and yellow fever (YF) vaccination campaign conducted in Cameroon in May 2009. We monitored 17 pre-selected districts at risk for low coverage. We designed LQAS plans to reject districts with YF vaccination coverage <90% and with OPV coverage <95%. In each lot the sample size was 50 (five clusters of 10) with decision values of 3 for assessing OPV and 7 for YF coverage. We 'rejected' 10 districts for low YF coverage and 14 for low OPV coverage. Hence we recommended a 2-day extension of the campaign. Clustered-LQAS proved to be useful in guiding the campaign vaccination strategy before the completion of the operations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21418714     DOI: 10.1017/S0950268811000331

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  8 in total

1.  Intervene before leaving: clustered lot quality assurance sampling to monitor vaccination coverage at health district level before the end of a yellow fever and measles vaccination campaign in Sierra Leone in 2009.

Authors:  Lorenzo Pezzoli; Ishata Conteh; Wogba Kamara; Marta Gacic-Dobo; Olivier Ronveaux; William A Perea; Rosamund F Lewis
Journal:  BMC Public Health       Date:  2012-06-07       Impact factor: 3.295

2.  Performance of small cluster surveys and the clustered LQAS design to estimate local-level vaccination coverage in Mali.

Authors:  Andrea Minetti; Margarita Riera-Montes; Fabienne Nackers; Thomas Roederer; Marie Hortense Koudika; Johanne Sekkenes; Aurore Taconet; Florence Fermon; Albouhary Touré; Rebecca F Grais; Francesco Checchi
Journal:  Emerg Themes Epidemiol       Date:  2012-10-12

3.  Multiple category-lot quality assurance sampling: a new classification system with application to schistosomiasis control.

Authors:  Casey Olives; Joseph J Valadez; Simon J Brooker; Marcello Pagano
Journal:  PLoS Negl Trop Dis       Date:  2012-09-06

4.  Whom and where are we not vaccinating? Coverage after the introduction of a new conjugate vaccine against group A meningococcus in Niger in 2010.

Authors:  Sung Hye Kim; Lorenzo Pezzoli; Harouna Yacouba; Tiekoura Coulibaly; Mamoudou H Djingarey; William A Perea; Thomas F Wierzba
Journal:  PLoS One       Date:  2012-01-20       Impact factor: 3.240

5.  Predictors to parental knowledge about childhood immunisation/EPI vaccines in two health districts in Cameroon prior to the introduction of 13-valent Pneumococcal Conjugate Vaccines (PCV-13).

Authors:  John Njuma Libwea; Marie Kobela; Jukka Ollgren; Irene Emah; Robert Tchio; Hanna Nohynek
Journal:  Pan Afr Med J       Date:  2014-03-11

Review 6.  Measuring coverage in MNCH: total survey error and the interpretation of intervention coverage estimates from household surveys.

Authors:  Thomas P Eisele; Dale A Rhoda; Felicity T Cutts; Joseph Keating; Ruilin Ren; Aluisio J D Barros; Fred Arnold
Journal:  PLoS Med       Date:  2013-05-07       Impact factor: 11.069

7.  Use of Mobile Information Technology during Planning, Implementation and Evaluation of a Polio Campaign in South Sudan.

Authors:  John Haskew; Veronica Kenyi; Juma William; Rebecca Alum; Anu Puri; Yehia Mostafa; Robert Davis
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

8.  The effect of clustering on lot quality assurance sampling: a probabilistic model to calculate sample sizes for quality assessments.

Authors:  Bethany L Hedt-Gauthier; Tisha Mitsunaga; Lauren Hund; Casey Olives; Marcello Pagano
Journal:  Emerg Themes Epidemiol       Date:  2013-10-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.